But many questions remain including its long-term safety profile, effect on lean body mass and bone mineral density, real-world tolerability, and ultimate UK pricing once and if MHRA approval is granted
Oral semaglutide may even lead to less nausea and vomiting than once-weekly dulaglutide and once-daily lixisenatide (two less common GLP-1 injectable medications), though its nausea profile is similar to that of injectable semaglutide
Despite largely acceptable profiles, cautious investigation is necessary for long-term safety issues
The D-glucose moiety is depicted in yellow, with heteroatoms coloured in red
The patches rely on herbal ingredients with weak or no clinical evidence for weight loss, especially through a patch
The goal is not the highest dose, but the effective dose you can maintain comfortably